RxDoctor Payments DataLook up a doctor →

John Roussalis

Plastic and Reconstructive Surgery · Newark, DENPI 1235252669

Payments from drug & device makers

$13,242in general payments, 2019–2025

Across 115 payments — averaging $115.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$8K
  • AbbVie$3K
  • BD$350
  • Johnson & Johnson$257
  • Convatec Inc.$207
  • UCB, Inc.$162
  • plus $1K from 21 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few plastic and reconstructive surgery providers in Delawareto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$3,505,777
Medicare patients
730
Services billed
5,661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →